Becton Dickinson Profit Margin 2006-2018 | BDX

Current and historical gross margin, operating margin and net profit margin for Becton Dickinson (BDX) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Becton Dickinson net profit margin as of June 30, 2018 is 4.73%.
Becton Dickinson Annual Profit Margin Summary
Becton Dickinson Quarterly Profit Margin Summary
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $69.973B $12.093B
Becton, Dickinson & Company is a global medical technology company that is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. BD leads in patient and health care worker safety and the technologies that enable medical research and clinical laboratories. The company provides innovative solutions that help advance medical research and genomics, enhance the diagnosis of infectious disease and cancer, improve medication management, promote infection prevention, equip surgical and interventional procedures, and support the management of diabetes. The company partners with organizations around the world to address some of the most challenging global health issues.
Stock Name Country Market Cap PE Ratio
Align Technology (ALGN) United States $30.589B 81.55
McKesson (MCK) United States $26.959B 10.32
AmerisourceBergen (ABC) United States $19.500B 14.17
Laboratory Of America Holdings (LH) United States $17.535B 16.13
Cardinal Health (CAH) United States $16.967B 11.45
Cooper (COO) United States $13.215B 23.80
Henry Schein (HSIC) United States $13.117B 22.37
West Pharmaceutical Services (WST) United States $8.942B 46.23
DENTSPLY SIRONA (XRAY) United States $8.618B 15.08
Merit Medical Systems (MMSI) United States $3.361B 44.17
Patterson (PDCO) United States $2.435B 17.11
CONMED (CNMD) United States $2.190B 37.10
STAAR Surgical (STAA) United States $2.063B 276.18
Atrion (ATRI) United States $1.219B 36.13
Antares Pharma (ATRS) United States $0.513B 0.00
Invacare (IVC) United States $0.490B 0.00
Lifevantage (LFVN) United States $0.168B 23.86
Endologix (ELGX) United States $0.152B 0.00
Aceto (ACET) United States $0.094B 3.80
Pro-Dex (PDEX) United States $0.055B 24.33
Biolase (BIOL) United States $0.045B 0.00